Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 2/20 | 0.59 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | CA4 | P22748 | 2/20 | 0.45 |
| ▸ | CA6 | P23280 | 2/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | TPMT | P51580 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CA3 | P07451 | 1/20 | 0.45 |
| ▸ | SELL | P14151 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2186294 | 0.86 | SLC6A2 (0.54) | PRMT1CSNK2A1ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL1681429 | 0.81 | PRMT1 (0.63) | PRMT1ALDH1A1SMN1; SMN2KDM4ECA12 | |
| SCHEMBL22663048 | 0.81 | ALDH1A1 (0.44) | PRMT1CSNK2A1ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL5860632 | 0.81 | TTR (0.46) | PRMT1CSNK2A1ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL15006668 | 0.79 | PRMT1 (0.59) | PRMT1ALDH1A1SMN1; SMN2KDM4ECA12 | |
| SCHEMBL30220366 | 0.79 | PRMT1 (0.59) | PRMT1ALDH1A1SMN1; SMN2KDM4ECA12 | |
| SCHEMBL27619808 | 0.79 | PRMT1 (0.59) | PRMT1ALDH1A1SMN1; SMN2KDM4ECA12 | |
| SCHEMBL741721 | 0.79 | PRMT1 (0.59) | PRMT1ALDH1A1SMN1; SMN2KDM4ECA12 | |
| SCHEMBL10279934 | 0.79 | PRMT1 (0.59) | PRMT1ALDH1A1SMN1; SMN2KDM4ECA12 | |
| SCHEMBL5735509 | 0.79 | PRMT1 (0.59) | PRMT1ALDH1A1SMN1; SMN2KDM4ECA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265066-A1 | NAPHTHOPYRAN-CONTAINING COMPOUND, POLYMER, MIXTURE, COMPOSITION AND USE THEREOF IN WATER-SOLUBLE PHOTOCHROMIC MATERIALS | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2023-08-24 | — | — | US | disclosed |
| WO-2023287067-A1 | ANTIBACTERIAL COMPOUND | 주식회사 엘지화학 | 2023-01-19 | — | — | WO | disclosed |
| EP-2343279-B1 | FUSED-RING DERIVATIVE AND MEDICAL APPLICATION OF SAME | KISSEI PHARMACEUTICAL (JP) | 2018-02-28 | — | — | EP | disclosed |
| US-9745336-B2 | Fluorescent dye compounds, conjugates and uses thereof | APPLIED BIOSYSTEMS, LLC (US) | 2017-08-29 | — | — | US | disclosed |
| US-20140303003-A1 | Fluorescent Dye Compounds, Conjugates and Uses Thereof | APPLIED BIOSYSTEMS, LLC (US) | 2014-10-09 | — | — | US | disclosed |
| US-8729267-B2 | Fluorescent dye compounds, conjugates and uses thereof | APPLIED BIOSYSTEMS, LLC (US) | 2014-05-20 | — | — | US | disclosed |
| CN-102186824-B | Fused-ring derivative and medical application of same | KISSEI PHARMACEUTICAL | 2014-03-12 | — | — | CN | disclosed |
| US-8263622-B2 | Fused-ring derivative and medical application of same | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2012-09-11 | — | — | US | disclosed |
| US-20110250699-A1 | Fluorescent Dye Compounds, Conjugates and Uses Thereof | Life Technologies Corporation (US) | 2011-10-13 | — | — | US | disclosed |
| CN-102186824-A | Fused-ring derivative and medical application of same | KISSEI PHARMACEUTICAL | 2011-09-14 | — | — | CN | disclosed |
| US-20110207935-A1 | FUSED-RING DERIVATIVE AND MEDICAL APPLICATION OF SAME | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2011-08-25 | — | — | US | disclosed |
| EP-2343279-A1 | FUSED-RING DERIVATIVE AND MEDICAL APPLICATION OF SAME | Kissei Pharmaceutical Co., Ltd. (JP) | 2011-07-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265066-A1 | NAPHTHOPYRAN-CONTAINING COMPOUND, POLYMER, MIXTURE, COMPOSITION AND USE THEREOF IN WATER-SOLUBLE PHOTOCHROMIC MATERIALS | TYR, PWWP2B, GANC | PRMT1 4679/4885CSNK2A1 1396/4885ALDH1A1 3291/4885 |
| US-20110207935-A1 | FUSED-RING DERIVATIVE AND MEDICAL APPLICATION OF SAME | XDH, OAT, PON1 | PRMT1 1250/4885CSNK2A1 3829/4885ALDH1A1 185/4885 |
| US-20110250699-A1 | Fluorescent Dye Compounds, Conjugates and Uses Thereof | GFPT1, SLC46A1, SLC7A5 | PRMT1 2119/4885CSNK2A1 4701/4885ALDH1A1 146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.